Alcentra Capital Corp (ABDC) Expected to Announce Quarterly Sales of $6.35 Million

Wall Street brokerages expect Alcentra Capital Corp (NASDAQ:ABDC) to post sales of $6.35 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Alcentra Capital’s earnings, with the highest sales estimate coming in at $6.71 million and the lowest estimate coming in at $5.84 million. Alcentra Capital reported sales of $8.18 million during the same quarter last year, which indicates a negative year-over-year growth rate of 22.4%. The business is scheduled to issue its next quarterly earnings report on Monday, May 6th.

According to Zacks, analysts expect that Alcentra Capital will report full-year sales of $25.20 million for the current year, with estimates ranging from $22.93 million to $27.28 million. For the next year, analysts anticipate that the firm will post sales of $27.06 million, with estimates ranging from $22.74 million to $30.00 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that follow Alcentra Capital.

Alcentra Capital (NASDAQ:ABDC) last announced its quarterly earnings results on Monday, March 11th. The asset manager reported $0.27 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.05. Alcentra Capital had a return on equity of 9.24% and a net margin of 19.06%. The firm had revenue of $6.98 million during the quarter, compared to analyst estimates of $6.62 million.

Several institutional investors have recently made changes to their positions in ABDC. Virtu Financial LLC purchased a new position in shares of Alcentra Capital in the 4th quarter valued at about $90,000. Millennium Management LLC purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $107,000. Squarepoint Ops LLC purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $165,000. Two Sigma Investments LP purchased a new stake in Alcentra Capital during the 4th quarter worth approximately $265,000. Finally, Mackenzie Financial Corp increased its stake in Alcentra Capital by 73.1% during the 3rd quarter. Mackenzie Financial Corp now owns 69,744 shares of the asset manager’s stock worth $417,000 after buying an additional 29,458 shares in the last quarter. Hedge funds and other institutional investors own 29.83% of the company’s stock.

Shares of Alcentra Capital stock traded up $0.06 on Friday, hitting $7.92. The company’s stock had a trading volume of 60,840 shares, compared to its average volume of 39,855. Alcentra Capital has a 1 year low of $5.58 and a 1 year high of $8.16. The firm has a market cap of $101.98 million, a PE ratio of 7.84 and a beta of 0.58.

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 4th. Investors of record on Friday, March 29th were paid a $0.18 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.72 annualized dividend and a dividend yield of 9.09%. Alcentra Capital’s dividend payout ratio is presently 71.29%.

Alcentra Capital Company Profile

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.

See Also: The risks of owning bonds

Get a free copy of the Zacks research report on Alcentra Capital (ABDC)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Alcentra Capital (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with's FREE daily email newsletter.